title: Development of a radioiodinated triazolopyrimidine probe for nuclear medical imaging of fatty acid binding protein 4.
abstract: Fatty acid binding protein 4 (FABP4) is the most well-characterized FABP isoform. FABP4 regulates inflammatory pathways in adipocytes and macrophages and is involved in both inflammatory diseases and tumor formation. FABP4 expression was recently reported for glioblastoma, where it may participate in disease malignancy. While FABP4 is a potential molecular imaging target, with the exception of a tritium labeled probe there are no reports of other nuclear imaging probes that target this protein. Here we designed and synthesized a nuclear imaging probe, [123I]TAP1, and evaluated its potential as a FABP4 targeting probe in in vitro and in vivo assays. We focused on the unique structure of a triazolopyrimidine scaffold that lacks a carboxylic acid to design the TAP1 probe that can undergo facilitated delivery across cell membranes. The affinity of synthesized TAP1 was measured using FABP4 and 8-anilino-1-naphthalene sulfonic acid. [125I]TAP1 was synthesized by iododestannylation of a precursor, followed by affinity and selectivity measurements using immobilized FABPs. Biodistributions in normal and C6 glioblastoma-bearing mice were evaluated, and excised tumors were subjected to autoradiography and immunohistochemistry. TAP1 and [125I]TAP1 showed high affinity for FABP4 (Ki = 44.5±9.8 nM, Kd = 69.1±12.3 nM). The FABP4 binding affinity of [125I]TAP1 was 11.5- and 35.5-fold higher than for FABP3 and FABP5, respectively. In an in vivo study [125I]TAP1 displayed high stability against deiodination and degradation, and moderate radioactivity accumulation in C6 tumors (1.37±0.24% dose/g 3 hr after injection). The radioactivity distribution profile in tumors partially corresponded to the FABP4 positive area and was also affected by perfusion. The results indicate that [125I]TAP1 could detect FABP4 in vitro and partly in vivo. As such, [125I]TAP1 is a promising lead compound for further refinement for use in in vivo FABP4 imaging.
authors.affiliation: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Kantaro
authors.initials: K
authors.lastname: Nishigori
authors.affiliation: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Temma
authors.affiliation: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Satoru
authors.initials: S
authors.lastname: Onoe
authors.affiliation: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Sotaro
authors.initials: S
authors.lastname: Sampei
authors.affiliation: Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Fuchu-Shi, Tokyo, Japan; Department of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Ikuo
authors.initials: I
authors.lastname: Kimura
authors.affiliation: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Ono
authors.affiliation: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Hideo
authors.initials: H
authors.lastname: Saji
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001345:Autoradiography; D002264:Carboxylic Acids / Q000737:chemistry; D002460:Cell Line; D045744:Cell Line, Tumor; D050556:Fatty Acid-Binding Proteins / Q000378:metabolism*; D007150:Immunohistochemistry; D007457:Iodine Radioisotopes / Q000737:chemistry*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011485:Protein Binding; D011743:Pyrimidines / Q000737:chemistry*; D011744:Pyrimidinones / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution; D014230:Triazoles / Q000737:chemistry*
chemical_list: D002264:Carboxylic Acids; C524662:FABP4 protein, rat; C493411:Fabp4 protein, mouse; D050556:Fatty Acid-Binding Proteins; D007457:Iodine Radioisotopes; D011743:Pyrimidines; D011744:Pyrimidinones; D014230:Triazoles; C030986:pyrimidine
references.citation: Chem Pharm Bull (Tokyo). 2012;60(1):164-8
references.pmid: 22223390
references.citation: J Nutr. 2004 Sep;134(9):2464S-2468S
references.pmid: 15333743
references.citation: J Lipid Res. 2011 Apr;52(4):646-56
references.pmid: 21296956
references.citation: J Nucl Med. 2008 Oct;49(10):1677-85
references.pmid: 18794262
references.citation: J Med Chem. 2009 Oct 8;52(19):6024-31
references.pmid: 19754198
references.citation: J Lipid Res. 1999 May;40(5):967-72
references.pmid: 10224167
references.citation: Bioorg Med Chem Lett. 2007 Jun 15;17(12):3511-5
references.pmid: 17502136
references.citation: J Nucl Med. 2010 Dec;51(12):1979-86
references.pmid: 21078793
references.citation: Bioorg Med Chem Lett. 2011 Nov 1;21(21):6523-6
references.pmid: 21917452
references.citation: Nat Rev Drug Discov. 2008 Jun;7(6):489-503
references.pmid: 18511927
references.citation: Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):889-99
references.pmid: 17216472
references.citation: J Intern Med. 2011 Feb;269(2):200-10
references.pmid: 21073559
references.citation: Nature. 2007 Jun 21;447(7147):959-65
references.pmid: 17554340
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5528-32
references.pmid: 10318917
references.citation: Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2093-104
references.pmid: 20625725
references.citation: BMC Cancer. 2011 Jul 18;11:302
references.pmid: 21767383
references.citation: Semin Nucl Med. 2012 Nov;42(6):356-70
references.pmid: 23026359
references.citation: Bioorg Med Chem Lett. 2010 Jun 15;20(12):3675-9
references.pmid: 20471252
references.citation: Nat Med. 2011 Oct 30;17(11):1498-503
references.pmid: 22037646
references.citation: Int J Cancer. 2009 Apr 15;124(8):1820-8
references.pmid: 19115207
references.citation: J Biol Chem. 2005 Apr 1;280(13):12888-95
references.pmid: 15684432
references.citation: Nucl Med Biol. 2013 May;40(4):445-50
references.pmid: 23528561
references.citation: Bioorg Med Chem Lett. 2011 May 15;21(10):2949-52
references.pmid: 21481589
references.citation: J Lipid Res. 2000 Dec;41(12):2017-23
references.pmid: 11108735
references.citation: Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1747-55
references.pmid: 17437104
references.citation: Bioorg Med Chem Lett. 2004 Sep 6;14(17):4449-52
references.pmid: 15357970
references.citation: Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2058-67
references.pmid: 19629477
references.citation: Neuropathol Appl Neurobiol. 2012 Aug;38(5):400-10
references.pmid: 22093167
references.citation: Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8
references.pmid: 15357969
references.citation: Am J Nucl Med Mol Imaging. 2012;2(4):432-47
references.pmid: 23145360
references.citation: Nucl Med Biol. 2013 Jan;40(1):97-103
references.pmid: 23157986